1. Home
  2. TEL vs IQV Comparison

TEL vs IQV Comparison

Compare TEL & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TEL

TE Connectivity Ltd. New Switzerland Registered Shares

HOLD

Current Price

$223.95

Market Cap

58.3B

Sector

Technology

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$171.85

Market Cap

28.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TEL
IQV
Founded
1941
1982
Country
Ireland
United States
Employees
N/A
93000
Industry
Industrial Machinery/Components
Biotechnology: Commercial Physical & Biological Resarch
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.3B
28.6B
IPO Year
2007
2013

Fundamental Metrics

Financial Performance
Metric
TEL
IQV
Price
$223.95
$171.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
16
Target Price
$258.00
$230.56
AVG Volume (30 Days)
1.7M
1.2M
Earning Date
04-22-2026
05-05-2026
Dividend Yield
1.35%
N/A
EPS Growth
N/A
4.67
EPS
2.53
7.84
Revenue
$17,262,000,000.00
$9,739,000,000.00
Revenue This Year
$13.91
$6.77
Revenue Next Year
$7.79
$5.87
P/E Ratio
$83.32
$21.79
Revenue Growth
8.94
41.60
52 Week Low
$123.28
$134.65
52 Week High
$250.67
$247.05

Technical Indicators

Market Signals
Indicator
TEL
IQV
Relative Strength Index (RSI) 61.32 50.68
Support Level $221.41 $159.42
Resistance Level $241.51 $193.26
Average True Range (ATR) 6.47 6.17
MACD 2.74 1.66
Stochastic Oscillator 95.71 63.81

Price Performance

Historical Comparison
TEL
IQV

About TEL TE Connectivity Ltd. New Switzerland Registered Shares

TE Connectivity is the largest electrical connector supplier in the world, supplying interconnect and sensor solutions to the transportation, industrial, and communications markets. With operations in 150 countries and over 500,000 stock-keeping units, TE has a broad portfolio that forms the electrical architecture of its end customers' cutting-edge innovations.

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Share on Social Networks: